| Primary |
| Type 2 Diabetes Mellitus |
53.4% |
| Product Used For Unknown Indication |
31.6% |
| Diabetes Mellitus |
4.8% |
| Hypertension |
3.4% |
| Drug Use For Unknown Indication |
0.8% |
| Obesity |
0.6% |
| Type 1 Diabetes Mellitus |
0.6% |
| Insulin-requiring Type 2 Diabetes Mellitus |
0.6% |
| Blood Cholesterol Increased |
0.5% |
| Weight Decreased |
0.5% |
| Hyperlipidaemia |
0.4% |
| Prophylaxis |
0.4% |
| Glucose Tolerance Impaired |
0.4% |
| Hypothyroidism |
0.3% |
| Hypercholesterolaemia |
0.3% |
| Dyslipidaemia |
0.3% |
| Asthma |
0.3% |
| Pain |
0.3% |
| Depression |
0.3% |
| Weight Control |
0.3% |
|
| Nausea |
21.3% |
| Pancreatitis |
11.7% |
| Blood Glucose Increased |
10.2% |
| Vomiting |
8.3% |
| Weight Decreased |
7.5% |
| Pancreatitis Acute |
5.6% |
| Diarrhoea |
5.0% |
| Decreased Appetite |
4.4% |
| Headache |
3.1% |
| Injection Site Haematoma |
2.9% |
| Constipation |
2.8% |
| Blood Glucose Decreased |
2.5% |
| Injection Site Reaction |
2.4% |
| Injection Site Pain |
2.3% |
| Drug Ineffective |
2.0% |
| Pancreatic Carcinoma |
1.8% |
| Abdominal Pain Upper |
1.8% |
| Weight Increased |
1.6% |
| Injection Site Rash |
1.4% |
| Urticaria |
1.4% |
|
| Secondary |
| Type 2 Diabetes Mellitus |
42.8% |
| Product Used For Unknown Indication |
33.3% |
| Hypertension |
7.0% |
| Diabetes Mellitus |
4.4% |
| Obesity |
1.8% |
| Blood Cholesterol Increased |
1.2% |
| Weight Decreased |
1.0% |
| Chronic Obstructive Pulmonary Disease |
0.8% |
| Prophylaxis |
0.8% |
| Type 1 Diabetes Mellitus |
0.7% |
| Hyperlipidaemia |
0.7% |
| Hypothyroidism |
0.7% |
| Dyslipidaemia |
0.7% |
| Drug Use For Unknown Indication |
0.7% |
| Diabetes Mellitus Inadequate Control |
0.7% |
| Hypercholesterolaemia |
0.6% |
| Pain |
0.6% |
| Asthma |
0.6% |
| Gastrooesophageal Reflux Disease |
0.6% |
| Bipolar Disorder |
0.5% |
|
| Pancreatitis |
14.4% |
| Pancreatitis Acute |
13.2% |
| Vomiting |
11.5% |
| Nausea |
10.3% |
| Weight Decreased |
9.4% |
| Blood Glucose Increased |
7.2% |
| Pancreatic Carcinoma |
4.7% |
| Diarrhoea |
3.9% |
| Cholelithiasis |
3.3% |
| Decreased Appetite |
2.5% |
| Weight Increased |
2.5% |
| Lipase Increased |
2.4% |
| Thyroid Cancer |
2.4% |
| Abdominal Pain Upper |
2.0% |
| Renal Failure |
2.0% |
| Renal Failure Acute |
2.0% |
| Ileus |
1.8% |
| Dehydration |
1.6% |
| Hepatic Function Abnormal |
1.5% |
| Abdominal Pain |
1.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
44.2% |
| Diabetes Mellitus |
14.2% |
| Type 2 Diabetes Mellitus |
13.9% |
| Hypertension |
6.4% |
| Pain |
2.5% |
| Blood Cholesterol Increased |
2.1% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Rheumatoid Arthritis |
1.9% |
| Depression |
1.4% |
| Psoriasis |
1.4% |
| Psoriatic Arthropathy |
1.4% |
| Asthma |
1.3% |
| Chronic Obstructive Pulmonary Disease |
1.1% |
| Atrial Fibrillation |
1.1% |
| Supplementation Therapy |
1.0% |
| Crohn's Disease |
0.8% |
| Hypersensitivity |
0.8% |
| Cardiac Failure Congestive |
0.8% |
| Hepatitis C |
0.8% |
| Blood Cholesterol |
0.7% |
|
| Flushing |
12.4% |
| Weight Decreased |
11.2% |
| Vomiting |
8.3% |
| Blood Glucose Increased |
7.0% |
| Nausea |
6.6% |
| Injection Site Pain |
5.4% |
| Weight Increased |
5.4% |
| Pruritus |
4.1% |
| Drug Ineffective |
3.7% |
| Off Label Use |
3.7% |
| Pain |
3.7% |
| Pancreatic Carcinoma |
3.7% |
| Paraesthesia |
3.7% |
| Pancreatitis |
3.3% |
| Rash |
3.3% |
| Renal Impairment |
3.3% |
| Wrong Technique In Drug Usage Process |
3.3% |
| Dizziness |
2.9% |
| Arthralgia |
2.5% |
| Feeling Hot |
2.5% |
|
| Interacting |
| Diabetes Mellitus |
19.4% |
| Product Used For Unknown Indication |
17.2% |
| Hypertension |
16.1% |
| Constipation |
6.5% |
| Dyslipidaemia |
6.5% |
| Neuropathy Peripheral |
6.5% |
| Cardiac Failure Congestive |
4.3% |
| Diabetes |
4.3% |
| Back Pain |
3.2% |
| Hypercholesterolaemia |
3.2% |
| Type 2 Diabetes Mellitus |
3.2% |
| Weight Loss Diet |
3.2% |
| Multiple Allergies |
2.2% |
| Blood Pressure High |
1.1% |
| Nerve Compression |
1.1% |
| Urinary Tract Infection |
1.1% |
| Weight Decreased |
1.1% |
|
| Drug Interaction |
33.3% |
| Drug Effect Delayed |
16.7% |
| Tension Headache |
16.7% |
| Myositis |
11.1% |
| Weight Increased |
11.1% |
| Fatigue |
5.6% |
| International Normalised Ratio Decreased |
5.6% |
|
